Institution
University of British Columbia
Education•Vancouver, British Columbia, Canada•
About: University of British Columbia is a education organization based out in Vancouver, British Columbia, Canada. It is known for research contribution in the topics: Population & Poison control. The organization has 89939 authors who have published 209679 publications receiving 9226862 citations. The organization is also known as: UBC & The University of British Columbia.
Papers published on a yearly basis
Papers
More filters
Université de Sherbrooke1, University of Alberta2, University of Lapland3, University of Victoria4, Wageningen University and Research Centre5, University of Alaska Fairbanks6, University of Oxford7, Université du Québec à Trois-Rivières8, Laval University9, St. John's University10, University of Amsterdam11, University of Vermont12, Aarhus University13, University of Zurich14, Swiss Federal Institute for Forest, Snow and Landscape Research15, University of Edinburgh16, La Trobe University17, Woods Hole Oceanographic Institution18, Lamont–Doherty Earth Observatory19, University of British Columbia20, University of Tromsø21, University of Alaska Anchorage22, Queen's University23, University of Virginia24
TL;DR: This article used repeat photography, long-term ecological monitoring and dendrochronology to document shrub expansion in arctic, high-latitude and alpine tundra.
Abstract: Recent research using repeat photography, long-term ecological monitoring and dendrochronology has documented shrub expansion in arctic, high-latitude and alpine tundra
1,153 citations
TL;DR: In this article, the authors hypothesize that independent institutions with long-term investments specialize in monitoring and influencing efforts rather than trading and show that only concentrated holdings by independent longterm institutions are related to post-merger performance.
1,152 citations
TL;DR: This paper found negative correlations between maximizing and happiness, optimism, self-esteem, and life satisfaction, and positive correlations between maximization and depression, perfectionism, and regret, and found that maximizers are less satisfied than non-maximizers with consumer decisions, and more likely to engage in social comparison.
Abstract: Can people feel worse off as the options they face increase? The present studies suggest that some people--maximizers--can. Study 1 reported a Maximization Scale, which measures individual differences in desire to maximize. Seven samples revealed negative correlations between maximization and happiness, optimism, self-esteem, and life satisfaction, and positive correlations between maximization and depression, perfectionism, and regret. Study 2 found maximizers less satisfied than nonmaximizers (satisficers) with consumer decisions, and more likely to engage in social comparison. Study 3 found maximizers more adversely affected by upward social comparison. Study 4 found maximizers more sensitive to regret and less satisfied in an ultimatum bargaining game. The interaction between maximizing and choice is discussed in terms of regret, adaptation, and self-blame.
1,151 citations
Brown University1, Harvard University2, International AIDS Society3, Stanford University4, University of British Columbia5, University of California, San Diego6, University of Alabama at Birmingham7, University of Colorado Denver8, Istituto Superiore di Sanità9, University of Paris10, University of California, San Francisco11
TL;DR: New data have provided a stronger rationale for earlier initiation of more aggressive therapy than previously recommended and reinforce the importance of careful selection of initial drug regimen for each patient for optimal long-term clinical benefit and adherence.
Abstract: Objective.—To provide recommendations for antiretroviral therapy based on information
available in mid-1998.Participants.—An international panel of physicians with expertise in antiretroviral
research and care of patients with human immunodeficiency virus (HIV) infection,
first convened by the International AIDS Society–USA in December 1995.Evidence.—The panel reviewed available clinical and basic science study
results (including phase 3 controlled trials; clinical, virologic, and immunologic
end point data; data presented at research conferences; and studies of HIV
pathophysiology); opinions of panel members were also considered. Recommendations
were limited to drugs available in mid-1998.Consensus Process.—Panel members monitor new clinical research reports and interim
results. The full panel meets regularly to discuss how the new information
may change treatment recommendations. Updated recommendations are developed
through consensus of the entire panel at each stage of development.Conclusions.—Accumulating data from clinical and pathogenesis studies continue
to support early institution of potent antiretroviral therapy in patients
with HIV infection. A variety of combination regimens show potency, expanding
choices for initial regimens for individual patients. Plasma HIV RNA assays
with increased sensitivity are important in monitoring therapeutic response;
however, more data are needed to determine precisely the HIV RNA levels that
define treatment failure. Long-term adverse drug effects are beginning to
emerge, requiring ongoing attention. Some issues regarding optimal long-term
approaches to antiretroviral management are unresolved. The increased complexity
in HIV management requires ongoing monitoring of new data for optimal treatment
of HIV infection.
1,151 citations
TL;DR: The technology needed to diagnose and quantitate the individual small airway and emphysema phenotypes present in people with COPD is being developed, and should prove helpful in the assessment of therapeutic interventions designed to modify the progress of either phenotype.
1,150 citations
Authors
Showing all 90682 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Gordon H. Guyatt | 231 | 1620 | 228631 |
| John C. Morris | 183 | 1441 | 168413 |
| Douglas Scott | 178 | 1111 | 185229 |
| John R. Yates | 177 | 1036 | 129029 |
| Deborah J. Cook | 173 | 907 | 148928 |
| Richard A. Gibbs | 172 | 889 | 249708 |
| Evan E. Eichler | 170 | 567 | 150409 |
| James F. Sallis | 169 | 825 | 144836 |
| Michael Snyder | 169 | 840 | 130225 |
| Jiawei Han | 168 | 1233 | 143427 |
| Michael Kramer | 167 | 1713 | 127224 |
| Bruce L. Miller | 163 | 1153 | 115975 |
| Peter A. R. Ade | 162 | 1387 | 138051 |
| Marc W. Kirschner | 162 | 457 | 102145 |
| Kaj Blennow | 160 | 1845 | 116237 |